The US Food and Drug Administration (FDA) has given positive feedback for Algernon Pharmaceuticals’ Phase IIb clinical trial of NP-120 (ifenprodil) for chronic cough treatment. A receptor antagonist of N-methyl-D-aspartate (NMDA), ifenprodil precisely acts on the NMDA-type subunit 2B (GluN2B). The agency offered the feedback at the pre-Investigational New Drug (pre-IND) meeting for the therapy.

For some time now, actors who simulate symptoms of specific diseases have been used to educate medical students. Today a robot called HAL S5301 (Kubrick forgive them) simulates a patient with brain injury: the manufacturing company believes it is a more effective and available alternative. Manufactured by US-based Gaumard Scientific, the S5301 is a life-sized adult humanoid […]

With a purpose to prepare their college students, medical faculties typically get actors to current signs of sure circumstances. Providing what’s claimed to be a extra constant and available various, the HAL S5301 robotic is designed to simulate a brain-injured affected person. Manufactured by Miami-based firm Gaumard Scientific, the S5301 is a life-sizeTa grownup humanoid […]